3-Year Outcomes With a Sirolimus-Coated Balloon for Femoropopliteal Disease
JACC: Cardiovascular Interventions · 2025-11 · 18 (21) · 2638-2640
DOI: 10.1016/j.jcin.2025.09.021 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Cardiovascular Interventions, 2025-11. Verfasst von Bernardo Cortese und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harrington Heart & Vascular Institute, University Hospitals, Cleveland, Ohio, USA; DCB Academy, Milan, Italy; Fondazione Ricerca e Innovazione Cardio…. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harrington Heart & Vascular Institute, University Hospitals, Cleveland, Ohio, USA; DCB Academy, Milan, Italy; Fondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy. Electronic address: bcortese@gmail.com.
- Harrington Heart & Vascular Institute, University Hospitals, Cleveland, Ohio, USA; DCB Academy, Milan, Italy.
Zitieren
APA
Cortese, B., & Frazzetto, M. (2025). 3-Year Outcomes With a Sirolimus-Coated Balloon for Femoropopliteal Disease. JACC: Cardiovascular Interventions, 18(21), 2638-2640. https://doi.org/10.1016/j.jcin.2025.09.021
Vancouver
Cortese B, Frazzetto M. 3-Year Outcomes With a Sirolimus-Coated Balloon for Femoropopliteal Disease. JACC: Cardiovascular Interventions. 2025;18(21):2638-2640. doi:10.1016/j.jcin.2025.09.021
BibTeX
@article{Cortese2025,
author = {Cortese, Bernardo and Frazzetto, Marco},
title = {3-Year Outcomes With a Sirolimus-Coated Balloon for Femoropopliteal Disease},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {21},
pages = {2638--2640},
doi = {10.1016/j.jcin.2025.09.021}
}
EUVIMED